secwatch.observer — SEC 8-K summary
======================================

Issuer:     OnKure Therapeutics, Inc. (OKUR)
CIK:        0001637715
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001193125-25-269652
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OnKure enters ATM offering agreement with Leerink Partners; up to 3% fee
------------------------------------------------------------------------

- Sales agreement with Leerink Partners for at-the-market offering of Class A common stock.
- Compensation set at 3.0% of gross proceeds from sales of Placement Shares.
- No minimum offering amount; company may suspend sales at any time.
- Sales commence only after SEC registration statement becomes effective.
- Agreement contains customary representations, warranties, and termination provisions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1637715/000119312525269652/0001193125-25-269652-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1637715/000119312525269652/okur-20251106.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-269652

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer